- Revenue increased 12.8% to a first
quarter record of $563.4 million
- Gross profit increased 20.1% to $136.8
million
- Operating income increased 24.5% to
$86.1 million
- Diluted earnings per common share
increased 23.9% to $0.57
- Non-GAAP diluted earnings per common
share increased 32.0% to $0.66
VCA Inc. (NASDAQ: WOOF), a leading animal
healthcare company in the United States and Canada, today reported
financial results for the first quarter ended March 31, 2016, as
follows: revenue increased 12.8% to a first quarter record of
$563.4 million; gross profit increased 20.1% to $136.8 million;
operating income increased 24.5% to $86.1 million; net income
increased 20.7% to $46.2 million; diluted earnings per common share
increased 23.9% to $0.57.
Excluding acquisition-related amortization expense, transaction
expenses related to the acquisition of Companion Animal Practices,
North America (“CAPNA”) and other discrete items detailed in this
press release, Non-GAAP operating income increased 27.6% to $95.2
million; Non-GAAP net income for the quarter increased 28.9% to
$53.7 million; and Non-GAAP diluted earnings per common share for
the quarter increased 32.0% to $0.66.
Bob Antin, Chairman and CEO, stated, "We had an outstanding
quarter highlighted by 32.0% growth in our adjusted diluted
earnings per common share. We have continued to experience
increasing organic revenue growth and gross margins in both our
core Animal Hospital and Laboratory business segments. Given our
results relative to our expectations and our future acquisition
pipeline, we are increasing our guidance for the full year ended
December 2016.
"Animal Hospital revenue in the first quarter increased 16.7%,
to $458.6 million, driven by acquisitions made during the past 12
months and same-store revenue growth of 7.6%. Our same-store gross
profit margin increased to 16.4%, from 14.3% in the prior-year
quarter and our total gross margin increased to 16.0%, from 14.1%
in the prior-year quarter. During the 2016 first quarter, we
acquired 24 independent animal hospitals which had historical
combined annual revenue of $84.0 million.
"Laboratory revenue increased 13.6%, to $106.7 million. Our
Laboratory internal revenue growth increased 9.1% to $102.5 million
from $94.0 million; laboratory gross profit margin increased 200
basis points to 53.1%, from 51.1%; and our operating margin
increased 190 basis points to 43.5%, from 41.6% in the prior-year
quarter."
2016 Guidance
We revise our previously provided guidance as follows:
- Revenue from $2.39 billion to $2.41
billion;
- Net income from $210 million to $218
million;
- Diluted earnings per common share from
$2.57 to $2.67; and
- Non-GAAP diluted earnings per common
share from $2.82 to $2.92.
The above revised guidance does not include the impact of the
CAPNA acquisition. Assuming a closing date during the second
quarter of 2016, we estimate an additional $0.03 to $0.04 in 2016
Non-GAAP adjusted diluted earnings per share excluding
amortization, transaction and integration costs.
Non-GAAP Financial Measures
We believe investors’ understanding of our total performance is
enhanced by disclosing Non-GAAP financial measures including
Non-GAAP net income, Non-GAAP gross profit, Non-GAAP operating
income and Non-GAAP diluted earnings per common share. We define
these adjusted measures as the reported amounts, adjusted to
exclude certain significant items and amortization of intangibles
acquired in acquisitions.
Management believes these adjusted measures are useful to
management and investors in evaluating the Company's operational
performance and their use provides an additional tool for
evaluating the Company's operating results and trends. As a result,
these Non-GAAP financial measures help to provide meaningful
comparisons of our overall performance from one reporting period to
another and meaningful assessments of related trends.
There is a material limitation associated with the use of these
Non-GAAP financial measures: our adjusted measures exclude the
impact of these significant items, and as a result, our computation
of adjusted diluted earnings per common share does not depict
diluted earnings per common share in accordance with GAAP.
To compensate for the limitations in the Non-GAAP financial
measures discussed above, our disclosures provide a complete
understanding of all adjustments found in Non-GAAP financial
measures, and we reconcile the Non-GAAP financial measures to the
GAAP financial measures in the attached financial schedules titled
“Supplemental Operating Data.”
Conference Call
We will discuss our first quarter 2016 financial results during
a conference call today, April 27th, at 9:00 a.m. Eastern Time. A
live broadcast of the call may be accessed by visiting our website
at investor.vca.com. The call may also be accessed by dialing (888)
311-3471. Interested parties should call at least ten minutes prior
to the start of the call to register. Replay of the webcast will be
available for ninety days by visiting the company's website.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Among the forward-looking statements in this press release
are statements addressing our 2016 guidance and plans,
expectations, future financial position and results of operation.
These forward-looking statements are not historical facts and are
inherently uncertain and out of our control. Any or all of our
forward-looking statements in this press release may turn out to be
wrong. They can be affected by inaccurate assumptions we might make
or by known or unknown risks and uncertainties. Actual future
results may vary materially. Among other factors that could cause
our actual results to differ from this forward-looking information
are: the continued effects of the economic uncertainty prevailing
in regions in which we operate; our ability to execute on our
growth strategy and to manage acquired operations; changes in
demand for our products and services; fluctuations in our revenue
adversely affecting our gross profit, operating income and margins;
our ability to consummate the acquisition of CAPNA; a material
adverse change in the financial condition or operations of either
company; the ability to successfully integrate the two companies
and achieve expected operating synergies following the transaction;
and the effects of the other factors discussed in our Annual Report
on Form 10-K, Reports on Form 10-Q and our other filings with the
SEC.
About VCA Inc.
We own, operate and manage the largest networks of freestanding
veterinary hospitals and veterinary-exclusive clinical laboratories
in the country. We also supply diagnostic imaging equipment to the
veterinary industry.
VCA Inc.
Condensed, Consolidated Income
Statements
(Unaudited)
(In thousands, except per share
amounts)
Three Months EndedMarch 31, 2016
2015 Revenue: Animal hospital $ 458,623 $ 393,026
Laboratory 106,727 93,972 All other 19,413 34,227 Intercompany
(21,324 ) (21,772 ) 563,439 499,453 Direct
costs 426,659 385,591 Gross profit: Animal hospital 73,417
55,484 Laboratory 56,716 47,982 All other 6,910 11,424 Intercompany
(263 ) (1,028 ) 136,780 113,862 Selling,
general and administrative expense: Animal hospital 12,085 11,221
Laboratory 10,296 8,865 All other 5,299 8,687 Corporate 22,448
15,625 50,128 44,398 Net loss on
sale or disposal of assets 563 335 Operating income
86,089 69,129 Interest expense, net 7,095 4,837 Other (income)
expense (264 ) 66 Income before provision for income taxes
79,258 64,226 Provision for income taxes 31,536 24,673
Net income 47,722 39,553 Net income attributable to
noncontrolling interests 1,495 1,252 Net income
attributable to VCA Inc. $ 46,227 $ 38,301 Diluted
earnings per share $ 0.57 $ 0.46 Weighted-average
shares outstanding for diluted earnings per share 81,523
83,373
VCA Inc.
Condensed, Consolidated Balance
Sheets
(Unaudited)
(In thousands)
March 31, 2016 December
31, 2015 Assets Current assets: Cash and cash
equivalents $ 74,480 $ 98,888 Trade accounts receivable, net 79,540
76,634 Inventory 54,961 51,523 Prepaid expenses and other 33,090
30,521 Prepaid income taxes 7,798 24,598 Total
current assets 249,869 282,164 Property and equipment, net 540,017
507,753 Other assets: Goodwill 1,656,389 1,517,650 Other intangible
assets, net 114,469 97,377 Notes receivable 5,472 2,194 Deferred
financing costs, net 5,699 6,133 Other 97,459 93,994
Total assets $ 2,669,374 $ 2,507,265
Liabilities
and Equity Current liabilities: Current portion of long-term
debt $ 33,947 $ 33,623 Accounts payable 46,573 52,337 Accrued
payroll and related liabilities 88,510 75,519 Other accrued
liabilities 77,417 70,828 Total current liabilities
246,447 232,307 Long-term debt, less current portion 924,322
838,851 Deferred income taxes 131,150 131,478 Other liabilities
39,167 36,084 Total liabilities 1,341,086 1,238,720
Redeemable noncontrolling interests 11,787 11,511 VCA Inc.
stockholders’ equity: Common stock 81 81 Additional paid-in capital
22,681 19,708 Retained earnings 1,321,434 1,275,207 Accumulated
other comprehensive loss (37,789 ) (50,034 ) Total VCA Inc.
stockholders’ equity 1,306,407 1,244,962 Noncontrolling interests
10,094 12,072 Total equity 1,316,501 1,257,034
Total liabilities and equity $ 2,669,374 $ 2,507,265
VCA Inc.
Condensed, Consolidated Statements of
Cash Flows
(Unaudited)
(In thousands)
Three Months EndedMarch 31, 2016
2015 Cash flows from operating activities: Net income
$ 47,722 $ 39,553 Adjustments to reconcile net income to net cash
provided by operating activities: Depreciation and amortization
21,289 19,797 Amortization of debt issue costs 434 434 Provision
for uncollectible accounts 851 1,183 Net loss on sale or disposal
of assets 563 335 Share-based compensation 4,906 4,132 Excess tax
benefit from stock based compensation (445 ) (791 ) Other 4,489
(989 ) Changes in operating assets and liabilities: Trade accounts
receivable (3,339 ) (14,570 ) Inventory, prepaid expense and other
assets (7,569 ) 2,862 Accounts payable and other accrued
liabilities (4,802 ) (6,954 ) Accrued payroll and related
liabilities 12,955 14,052 Income taxes 16,855 21,581
Net cash provided by operating activities 93,909 80,625
Cash flows from investing activities: Business acquisitions,
net of cash acquired (160,385 ) (33,652 ) Property and equipment
additions (25,806 ) (16,526 ) Proceeds from sale of assets 12 92
Other (7,346 ) (576 ) Net cash used in investing activities
(193,525 ) (50,662 ) Cash flows from financing activities:
Repayment of debt (9,678 ) (5,165 ) Proceeds from revolving credit
facility 90,000 — Distributions to non-controlling interest
partners (1,238 ) (1,325 ) Purchase of non-controlling interests
(3,730 ) (1,483 ) Proceeds from issuance of common stock under
stock option plans 286 404 Excess tax benefit from stock based
compensation 445 791 Repurchase of common stock (843 ) (44,845 )
Other (333 ) (80 ) Net cash provided (used) in financing activities
74,909 (51,703 ) Effect of currency exchange rate changes on
cash and cash equivalents 299 (365 ) Decrease in cash and cash
equivalents (24,408 ) (22,105 ) Cash and cash equivalents at
beginning of period 98,888 81,383 Cash and cash
equivalents at end of period $ 74,480 $ 59,278
VCA Inc.
Supplemental Operating Data
(Unaudited - In thousands, except per
share amounts)
Table #1
Reconciliation of net income attributable to
Three Months EndedMarch 31, VCA Inc., to Non-GAAP
net income attributable to VCA Inc. (1)
2016 2015 Net income
attributable to VCA Inc. $ 46,227 $ 38,301 Adjustments to Other
Long-term liabilities, net of tax (2) 2,040 — Discrete tax items
(3) 1,045 — Transaction costs related to the CAPNA acquisition, net
of tax (4) 587 — Acquisitions related amortization, net of tax (1)
3,791 3,363 Non-GAAP net income attributable to VCA
Inc. $ 53,690 $ 41,664
Table #2
Three Months EndedMarch 31, Reconciliation of
diluted earnings per share to Non-GAAP diluted earnings per
share (1) 2016 2015
Diluted earnings per share $ 0.57 $ 0.46 Adjustments to Other
Long-term liabilities, net of tax (2) 0.02 — Discrete tax items (3)
0.01 — Transaction costs related to the CAPNA acquisition, net of
tax (4) 0.01 — Acquisitions related amortization, net of tax (1)
0.05 0.04 Non-GAAP diluted earnings per share $ 0.66
$ 0.50 Shares used for computing diluted earnings per
share 81,523 83,373
Table #3
Three Months EndedMarch 31, Reconciliation of
consolidated gross profit to Non-GAAP consolidated gross
profit (1) 2016 2015
Consolidated gross profit $ 136,780 $ 113,862 Acquisitions related
amortization (1) 6,228 5,465 Non-GAAP consolidated
gross profit $ 143,008 $ 119,327 Non-GAAP
consolidated gross profit margin 25.4 % 23.9 %
Table
#4 Three Months EndedMarch 31, Reconciliation
of consolidated operating income to Non-GAAP consolidated
operating income (1) 2016 2015
Consolidated operating income $ 86,089 $ 69,129
Adjustments to Other Long-term liabilities (2) 1,954 — Transaction
costs related to the CAPNA acquisition (4) 966 — Acquisitions
related amortization (1) 6,228 5,526 Non-GAAP
consolidated operating income $ 95,237 $ 74,655
Non-GAAP consolidated operating margin 16.9 % 14.9 %
VCA Inc.
Supplemental Operating Data
(cont)
(Unaudited - In thousands, except per
share amounts)
_________________________________________________
(1)
Management believes that investors'
understanding of our performance is enhanced by disclosing adjusted
measures as the reported amounts, adjusted to exclude certain
significant items and acquisition-related amortization. Non-GAAP
net income, Non-GAAP diluted earnings per common share, Non-GAAP
consolidated gross profit and Non-GAAP consolidated operating
income measures are not, and should not be viewed as substitutes
for U.S. generally accepted accounting principles (GAAP) net
income, its components and diluted earnings per share.
(2)
We recorded a non-cash charge to adjust
certain long-term liabilities for $3.4 million, or $2.0 million net
of tax. $2.0 million of this amount relates to compensation and
$1.4 million relates to interest accretion.
(3)
We recorded a tax adjustment to our income
tax liabilities for $1.0 million.
(4) In the first quarter of 2016, we recorded transaction
costs of $966,000, or $587,000 net of tax related to our
acquisition of CAPNA.
VCA Inc.
Supplemental Operating Data
(cont)
(Unaudited - In thousands, except per
share amounts)
As of Table #5
March 31, 2016
December 31, 2015 Selected consolidated
balance sheet data Debt: Senior term notes $ 577,500 $ 585,000
Revolving credit 322,000 232,000 Other debt and capital leases
58,769 55,474 Total debt $ 958,269 $ 872,474
Three Months EndedMarch 31, Table
#6
Selected expense data
2016 2015 Rent expense $ 20,864 $
18,780
Depreciation and amortization included in
direct costs:
Animal hospital $ 17,524 $ 15,962 Laboratory 2,748 2,475 All other
752 940 Intercompany (586 ) (523 ) $ 20,438 $ 18,854
Depreciation and amortization included in
selling, general and administrative expense
851 943 Total depreciation and amortization $ 21,289
$ 19,797 Share-based compensation included in
direct costs: Laboratory $ 177 $ 161
Share-based compensation included in
selling, general and administrative expense:
Animal hospital 784 664 Laboratory 429 366 All other 153 202
Corporate 3,363 2,739 4,729 3,971 Total
share-based compensation $ 4,906 $ 4,132
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160427005394/en/
VCA Inc.Tomas Fuller, 310-571-6505Chief Financial Officer
Petco Health and Wellness (NASDAQ:WOOF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Petco Health and Wellness (NASDAQ:WOOF)
Historical Stock Chart
From Apr 2023 to Apr 2024